A systematic review and meta-analysis of neuropathic pain associated with coronavirus disease 2019.
Giulia Di StefanoPietro FalcoEleonora GalosiGiuseppe Di PietroCaterina LeoneAndrea TruiniPublished in: European journal of pain (London, England) (2022)
Emerging evidence supports the development of neuropathic pain as a complication of COVID-19. However, longitudinal studies enrolling consecutive patients with COVID-19 that detail the diagnostic criteria for neuropathic pain are needed to better assess the frequency of this condition.